XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning Balance at Dec. 31, 2020 $ 8 $ 424,823 $ (317,506)   $ 107,325
Beginning Balance (in shares) at Dec. 31, 2020 81,669,151        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss     (65,101)   (65,101)
Stock-based compensation   4,462     4,462
Stock-based compensation - earnout   12,373     12,373
Issuance of common stock for acquisitions   1,169     1,169
Issuance of common stock for acquisitions (in shares) 90,000        
Reclassification of earnout liability upon vesting   25,815     25,815
Vesting of restricted stock awards (in shares) 2,078,102        
Exercise of stock warrants $ 1 93,007     93,008
Exercise of stock warrants (in shares) 8,087,623        
Exercise of stock options   355     355
Exercise of stock options (in shares) 593,106        
Income tax withholdings   (16,997)     (16,997)
Income tax withholdings (in shares) (1,062,250)        
Transaction costs   (402)     (402)
Ending Balance at Mar. 31, 2021 $ 9 544,605 (382,607)   162,007
Ending Balance (in shares) at Mar. 31, 2021 91,455,732        
Beginning Balance at Dec. 31, 2020 $ 8 424,823 (317,506)   107,325
Beginning Balance (in shares) at Dec. 31, 2020 81,669,151        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (81,398)
Ending Balance at Jun. 30, 2021 $ 10 627,396 (398,903) $ 267 228,770
Ending Balance (in shares) at Jun. 30, 2021 96,293,416        
Beginning Balance at Mar. 31, 2021 $ 9 544,605 (382,607)   162,007
Beginning Balance (in shares) at Mar. 31, 2021 91,455,732        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss     (16,296)   (16,296)
Other comprehensive income       267 267
Stock-based compensation   2,466     2,466
Stock-based compensation - earnout   4,176     4,176
Issuance of common stock for acquisitions   28,372     28,372
Issuance of common stock for acquisitions (in shares) 1,292,441        
Reclassification of private warrant liability upon exercise   16,843     16,843
Vesting of restricted stock awards (in shares) 33,182        
Exercise of stock warrants $ 1 33,761     33,762
Exercise of stock warrants (in shares) 2,862,312        
Exercise of stock options   2,227     2,227
Exercise of stock options (in shares) 946,392        
Income tax withholdings   (5,194)     (5,194)
Income tax withholdings (in shares) (296,643)        
Transaction costs   140     140
Ending Balance at Jun. 30, 2021 $ 10 627,396 (398,903) 267 228,770
Ending Balance (in shares) at Jun. 30, 2021 96,293,416        
Beginning Balance at Dec. 31, 2021 $ 10 641,406 (424,112) (259) 217,045
Beginning Balance (in shares) at Dec. 31, 2021 97,961,597        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss     (5,796)   (5,796)
Other comprehensive income       (2,515) (2,515)
Stock-based compensation   5,854     5,854
Contingent consideration for acquisitions   530     530
Vesting of restricted stock awards (in shares) 245,855        
Exercise of stock options   473     473
Exercise of stock options (in shares) 185,685        
Income tax withholdings   (712)     (712)
Income tax withholdings (in shares) (95,951)        
Ending Balance at Mar. 31, 2022 $ 10 647,551 (429,908) (2,774) 214,879
Ending Balance (in shares) at Mar. 31, 2022 98,297,186        
Beginning Balance at Dec. 31, 2021 $ 10 641,406 (424,112) (259) 217,045
Beginning Balance (in shares) at Dec. 31, 2021 97,961,597        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (32,173)
Ending Balance at Jun. 30, 2022 $ 10 659,814 (456,285) (4,559) 198,980
Ending Balance (in shares) at Jun. 30, 2022 99,440,528        
Beginning Balance at Mar. 31, 2022 $ 10 647,551 (429,908) (2,774) 214,879
Beginning Balance (in shares) at Mar. 31, 2022 98,297,186        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss     (26,377)   (26,377)
Other comprehensive income       (1,785) (1,785)
Stock-based compensation   9,702     9,702
Issuance of common stock for acquisitions   3,552     3,552
Issuance of common stock for acquisitions (in shares) 628,660        
Vesting of restricted stock awards (in shares) 563,406        
Exercise of stock options   219     219
Exercise of stock options (in shares) 88,772        
Income tax withholdings   (1,210)     (1,210)
Income tax withholdings (in shares) (137,496)        
Ending Balance at Jun. 30, 2022 $ 10 $ 659,814 $ (456,285) $ (4,559) $ 198,980
Ending Balance (in shares) at Jun. 30, 2022 99,440,528